EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis

Hiba J Mustafa, Enaja V Sambatur, Giorgio Pagani, Francesco D'Antonio, Emeline Maisonneuve, Paul Maurice, Carolien Zwiers, Joanne E J T Verweij, Anna Flood, Alireza A Shamshirsaz, Jean-Marie Jouannic, Asma Khalil

American Journal of Obstetrics and Gynecology · 2024-10 · 231 (4) · 417-429.e21

DOI: 10.1016/j.ajog.2024.03.044 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift American Journal of Obstetrics and Gynecology, 2024-10. Verfasst von Hiba J Mustafa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Indiana University School of Medicine, Indianapolis, IN; Fetal Center at Riley Children's and Indiana University…. Hauptthemen laut MEDLINE: Blood Transfusion, Intrauterine, Erythroblastosis, Fetal, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Royal Society of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to investigate the outcomes associated with the administration of maternal intravenous immunoglobulin in high-risk red blood cell-alloimmunized pregnancies. DATA SOURCES: Medline, Embase, and Cochrane Library were systematically searched until June 2023. STUDY ELIGIBILITY CRITERIA: This review included studies reporting on pregnancies with severe red blood cell alloimmunization, defined as either a previous fetal or neonatal death or the need for intrauterine transfusion before 24 weeks of gestation in the previous pregnancy as a result of hemolytic disease of the fetus and newborn. METHODS: Cases were pregnancies that received intravenous immunoglobulin, whereas controls did not. Individual patient data meta-analysis was performed using the Bayesian framework. RESULTS: Individual patient data analysis included 8 studies consisting of 97 cases and 97 controls. Intravenous immunoglobulin was associated with prolonged delta gestational age at the first intrauterine transfusion (gestational age of current pregnancy - gestational age at previous pregnancy) (mean difference, 3.19 weeks; 95% credible interval, 1.28-5.05), prolonged gestational age at the first intrauterine transfusion (mean difference, 1.32 weeks; 95% credible interval, 0.08-2.50), reduced risk of fetal hydrops at the time of first intrauterine transfusion (incidence rate ratio, 0.19; 95% credible interval, 0.07-0.45), reduced risk of fetal demise (incidence rate ratio, 0.23; 95% credible interval, 0.10-0.47), higher chances of live birth at ≥28 weeks (incidence rate ratio, 1.88; 95% credible interval, 1.31-2.69;), higher chances of live birth at ≥32 weeks (incidence rate ratio, 1.93; 95% credible interval, 1.32-2.83), and higher chances of survival at birth (incidence rate ratio, 1.82; 95% credible interval, 1.30-2.61). There was no substantial difference in the number of intrauterine transfusions, hemoglobin level at birth, bilirubin level at birth, or survival at hospital discharge for live births. CONCLUSION: Intravenous immunoglobulin treatment in pregnancies at risk of severe early hemolytic disease of the fetus and newborn seems to have a clinically relevant beneficial effect on the course and severity of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Transfusion, IntrauterineErythroblastosis, FetalImmunoglobulins, IntravenousFemaleHumansInfant, NewbornPregnancyGestational AgeHydrops FetalisRh Isoimmunization

Stichwörter der Autor:innen

blood transfusionerythroblastosisfetalimmunoglobulinintrauterineintravenousmeta-analysissystematic review

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Indiana University School of Medicine, Indianapolis, IN; Fetal Center at Riley Children's and Indiana University Health, Indianapolis, IN. Electronic address: hmustafa@iu.edu.
  • Division of Fetal Medicine and Surgery, Maternal Fetal Care Center, Boston Children's Hospital and Harvard School of Medicine, Boston, MA.
  • Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo, Italy.
  • Department of Obstetrics and Gynecology, Center for Fetal Care and High-Risk Pregnancy, University Hospital of Chieti, Chieti, Italy.
  • Materno-Fetal and Obstetrics Research Unit, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland; Fetal Medicine Department and French Referral National Centre for Perinatal Hemobiology, Ar…
  • Fetal Medicine Department and French Referral National Centre for Perinatal Hemobiology, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris Sorbonne Université, Paris, France.

Förderung

  • Royal Society of Medicine

Zitieren

APA

Mustafa, H. J., Sambatur, E. V., Pagani, G., D'Antonio, F., Maisonneuve, E., Maurice, P., Zwiers, C., Verweij, J. E. J. T., Flood, A., Shamshirsaz, A. A., Jouannic, J. M., & Khalil, A. (2024). Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis. American Journal of Obstetrics and Gynecology, 231(4), 417-429.e21. https://doi.org/10.1016/j.ajog.2024.03.044

Vancouver

Mustafa HJ, Sambatur EV, Pagani G, D'Antonio F, Maisonneuve E, Maurice P, et al. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis. American Journal of Obstetrics and Gynecology. 2024;231(4):417-429.e21. doi:10.1016/j.ajog.2024.03.044

BibTeX
@article{Mustafa2024,
  author = {Mustafa, Hiba J and Sambatur, Enaja V and Pagani, Giorgio and D'Antonio, Francesco and Maisonneuve, Emeline and Maurice, Paul and Zwiers, Carolien and Verweij, Joanne E J T and Flood, Anna and Shamshirsaz, Alireza A and Jouannic, Jean-Marie and Khalil, Asma},
  title = {Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis},
  journal = {American Journal of Obstetrics and Gynecology},
  year = {2024},
  volume = {231},
  number = {4},
  pages = {417--429.e21},
  doi = {10.1016/j.ajog.2024.03.044}
}
Kostenlos starten →